THE FDA HAS OPTIONS
The FDA had, and still has, options for approving Provenge now and obtaining additional data to continue evaluating this treatment...

FDA criticized for delay in prostate cancer drug
Philadelphia Inquirer news story..

PROVENGE NOW MAKES PROGRESS WITH ADVOCACY ACTIVITIES
A meeting with FDA Commisioner Dr. Andrew Von Eschenbach and a summary of June 4th and 5th activities in Washington, DC....

BLACK WEDNESDAY AT THE FDA - Wall Street Journal


ABC news
June 4 ABC TV news story...

PROMISING CANCER DRUG AWAITS OK FROM FDA
A survivor's story...

DID THE FDA TURN ITS BACK ON BLACK MEN...
Black men in the U. S. suffer a prostate cancer mortality rate 140% higher than for all other men..

IS THIS A TRANSPARENT CONFLICT OF INTEREST?
There is an uproar over the relationships of Dr. Howard Scher and Dr. Maha Hussain with the company Novacea. Both doctors lobbied against Provenge....

David...How Sad
Dear Dr. Von Eschenbach...

HONORING BLACK MEN WITH GOOD SCIENCE
Dr. Mary S. Harris, Journey to Wellness, views on "Did The FDA Turn Its Back On Black Men"

HONORING BLACK MEN THROUGH GOOD JUDGMENTS
Why Wait For A New Prostate Cancer Treatment In The Face Of An Epidemic?

DR. MARK MOYAD SPEAKS AT PROVENGENOW RALLY
June 4th ProvengeNow Rally

NEW STUDY SUPPORTS PROSTATE CANCER VACCINES
A National Institute of Health study comments on provenge and others..